IVD (In Vitro Diagnostics) Directive due for final adoption:
This article was originally published in Clinica
The European Union's In Vitro Diagnostics Directive could be finally adopted at the European Council of Ministers meeting on October 5. The text will go before a political meeting of the Committee of Permanent Representatives (COREPER) this week where it should be recommended to the Council of Ministers for adoption. A September 17 meeting of COREPER technical experts agreed all the amendments to the Directive.
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.